TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER IMAGE: IN HIS MOST RECENT STUDY, TTUHSC’S VARDAN KARAMYAN, PH.D., LED A COLLABORATIVE INVESTIGATION TO EVALUATE THE POTENTIAL OF NEUROLYSIN AS A THERAPEUTIC TARGET FOR STROKE. CREDIT: TTUHSC Ischemic stroke, the second leading cause of death worldwide, occurs when a vessel to the brain is blocked, reducing blood flow...
